Search
Patexia Research
Case number 2019-1513

Pfizer, Inc. v. Chugai Pharmaceutical Co. Ltd > Documents

Date Field Doc. No.Description (Pages)
Apr 23, 2021 0 PFIZER, INC. v. CHUGAI PHARMACEUTICAL CO. LTD [OPINION] [nonprecedential] (0)
Jun 3, 2020 74 Mandate issued to the United States Patent and Trademark Office. Service as of this date by the Clerk of Court. [698858] [19-1513, 19-1514] [MJL] [Entered: 06/03/2020 10:16 AM] (0)
Apr 27, 2020 72 OPINION filed for the court by Prost, Chief Judge; Bryson, Circuit Judge and Dyk, Circuit Judge. Nonprecedential Opinion. [690000] [19-1513, 19-1514] [JAB] [Entered: 04/27/2020 09:17 AM] (0)
Apr 27, 2020 73 JUDGMENT. DISMISSED. Terminated on the merits after oral argument. COSTS: No Costs. Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [690001] [19-1513, 19-1514] [JAB] [Entered: 04/27/2020 09:18 AM] (0)
Apr 10, 2020 71 Submitted after ORAL ARGUMENT by John P. Scheibeler for Pfizer, Inc. and Mr. Jon Steven Baughman for Chugai Pharmaceutical Co. Ltd. Panel: Judge: Prost , Judge: Bryson , Judge: Dyk. [685914] [JCP] [Entered: 04/10/2020 10:35 AM] (0)
Mar 26, 2020 70 Clerk's Letter to Appellant Pfizer, Inc. and Appellee Chugai Pharmaceutical Co. Ltd. (April 2020 Telephonic Argument Orientation). Service as of this date by the Clerk of Court. [682140] [JBP] [Entered: 03/26/2020 03:42 PM] (0)
Mar 12, 2020 69 ORDER filed. The court will conduct argument in this case by telephone at the originally scheduled date and time in lieu of in-person appearance. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [678108] [MJL] [Entered: 03/12/2020 09:49 AM] (0)
Mar 10, 2020 68 Response to notice of oral argument from the Appellant Pfizer, Inc.. [677529] [19-1513] [John Scheibeler] [Entered: 03/10/2020 11:31 AM] (0)
Mar 5, 2020 67 Response to notice of oral argument from the Appellee Chugai Pharmaceutical Co. Ltd.. [676567] [19-1513] [Jon Baughman] [Entered: 03/05/2020 12:29 PM] (0)
Feb 25, 2020 65 SUR-REPLY BRIEF FILED for Appellee Chugai Pharmaceutical Co. Ltd. Number of Pages: 13. Service: 12/16/2019 by email. Paper copies due 03/03/2020. [674144] [JAB] [Entered: 02/25/2020 03:47 PM] (0)
Feb 25, 2020 64 ORDER filed granting motion to file a response/reply [46] filed by Appellee Chugai Pharmaceutical Co. Ltd. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [674141] [JAB] [Entered: 02/25/2020 03:44 PM] (0)
Feb 21, 2020 63 NOTICE OF ORAL ARGUMENT. Panel: 2004O. Case scheduled April 10, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 203. Response to Notice of Oral Argument due: 03/16/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [673344] [JAB] [Entered: 02/21/2020 03:04 PM] (2)
Feb 14, 2020 62 The following conflict dates submitted by Attorney Jon Steven Baughman for Appellee Chugai Pharmaceutical Co. Ltd. have been accepted by the court: 06/04/2020, 06/05/2020, 07/06/2020, 07/07/2020, 08/03/2020, 08/04/2020, 08/05/2020, 08/06/2020, 08/07/2020. [671256] [JAB] [Entered: 02/14/2020 07:40 AM] (0)
Feb 13, 2020 61 Notice from Appellee Chugai Pharmaceutical Co. Ltd. regarding conflicts with oral argument. Service: 02/13/2020 by email. [671184] [19-1513] [Jon Baughman] [Entered: 02/13/2020 04:54 PM] (4)
Feb 13, 2020 60 Notice from Appellant Pfizer, Inc. regarding conflicts with oral argument. None. Service: 02/13/2020 by email. [671138] [19-1513] [John Scheibeler] [Entered: 02/13/2020 03:39 PM] (0)
Feb 11, 2020 66 6 paper copies of the Reply Brief [65] received from Appellee Chugai Pharmaceutical Co. Ltd. [674150] [JAB] [Entered: 02/25/2020 03:55 PM] (0)
Feb 11, 2020 59 6 paper copies of the Opening Brief [23] received from Appellant Pfizer, Inc. [670934] [CJF] [Entered: 02/13/2020 07:05 AM] (0)
Feb 11, 2020 58 6 paper copies of the Opening Response Brief [26] received from Appellee Chugai Pharmaceutical Co. Ltd. [670933] [CJF] [Entered: 02/13/2020 07:04 AM] (0)
Feb 11, 2020 57 6 paper copies of the Corrected Reply Brief [49] received from Appellant Pfizer, Inc. [670932] [CJF] [Entered: 02/13/2020 07:03 AM] (0)
Feb 11, 2020 56 6 paper copies of the Corrected Appendix (Vol. I - II) [50] received from Appellant Pfizer, Inc. and Appellee Chugai Pharmaceutical Co. Ltd. [670931] [CJF] [Entered: 02/13/2020 07:02 AM] (0)
Feb 7, 2020 55 Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [669238] [TAM] [Entered: 02/07/2020 09:19 AM] (1)
Feb 7, 2020 54 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [669237] [TAM] [Entered: 02/07/2020 09:19 AM] (0)
Jan 22, 2020 53 ORDER filed deferring motion [46] to merits panel assigned to hear this case. A copy of this order and the motion papers shall be transmitted to the assigned merits panel. Service as of this date by the Clerk of Court. [665100] [NL] [Entered: 01/22/2020 12:42 PM] (2)
Dec 24, 2019 52 REPLY of Appellee Chugai Pharmaceutical Co. Ltd. to response [51]. Service: 12/24/2019 by email. [658708] [19-1513] [Jon Baughman] [Entered: 12/24/2019 09:45 AM] (7)
Dec 20, 2019 51 RESPONSE of Appellant Pfizer, Inc. to the motion to file a response/reply [46] filed by Appellee Chugai Pharmaceutical Co. Ltd.. Service: 12/20/2019 by email. [658314] [19-1513] [John Scheibeler] [Entered: 12/20/2019 04:43 PM] (7)
Dec 19, 2019 50 MODIFIED ENTRY: CORRECTED APPENDIX FILED for Pfizer, Inc. and Chugai Pharmaceutical Co. Ltd.. Number of Pages: 990. Service: 12/19/2019 by email. [657904] --[Edited 02/07/2020 by TAM - compliance review complete] [John Scheibeler] [Entered: 12/19/2019 03:53 PM] (990)
Dec 19, 2019 49 MODIFIED ENTRY: CORRECTED REPLY BRIEF FILED for Appellant Pfizer, Inc.. Number of Pages: 24. Service: 12/19/2019 by email. [657900] --[Edited 01/31/2020 by TAM - compliance review complete] [John Scheibeler] [Entered: 12/19/2019 03:50 PM] (33)
Dec 19, 2019 48 Notice of Correction to Doc No. [31], [37] for Appellant Pfizer, Inc.. Service: 12/19/2019 by email. [657896] [19-1513] [John Scheibeler] [Entered: 12/19/2019 03:49 PM] (4)
Dec 18, 2019 47 NOTICE OF NON-COMPLIANCE: The submissions of Appellant Pfizer, Inc., Reply Brief and Supplemental Appendix [31], [45], are not in compliance with the rules of this court (see attached). Compliant documents due on 12/27/2019. Service as of this date by the Clerk of Court. [657476] [TAM] [Entered: 12/18/2019 11:45 AM] (2)
Dec 16, 2019 46 MOTION of Appellee Chugai Pharmaceutical Co. Ltd. for leave to file a response/reply to [31] Brief [Consent: opposed]. Service: 12/16/2019 by email. [656951] [19-1513] [Jon Baughman] [Entered: 12/16/2019 06:06 PM] (31)
Dec 16, 2019 45 FILED from Appellant Pfizer, Inc.. Title: SUPPLEMENTAL APPENDIX. Service: 12/16/2019 by email. [656873] [19-1513] This document is non-compliant. See Doc No.[47] [John Scheibeler] [Entered: 12/16/2019 03:51 PM] (45)
Dec 13, 2019 44 ORDER filed denying [30] motion for leave to file supplemental brief; denying [34] motion to stay appeal. Service as of this date by the Clerk of Court. [656546] [NL] [Entered: 12/13/2019 03:19 PM] (2)
Dec 13, 2019 43 ORDER filed granting motion [29] to the extent that Pfizer may include the declaration in the joint appendix. A copy of this order and the motion papers shall be transmitted to the merits panel assigned to this case. - FOR CALENDAR.. Service as of this date by the Clerk of Court. [656544] [NL] [Entered: 12/13/2019 03:14 PM] (2)
Dec 11, 2019 42 ORDER granting motion to extend time to file other [41] filed by Appellant Pfizer, Inc. Service as of this date by the Clerk of Court. [655609] [LMS] [Entered: 12/11/2019 11:34 AM] (2)
Dec 10, 2019 41 MOTION of Appellant Pfizer, Inc. to extend the time to 12/04/2019 to file Response/Reply [Consent: unopposed]. Service: 12/10/2019 by email. [655285] [19-1513] [Catalin Zonte] [Entered: 12/10/2019 12:23 PM] (10)
Dec 9, 2019 40 RESPONSE of Appellee Chugai Pharmaceutical Co. Ltd. to the motion [34] , motion [34]. Service: 12/09/2019 by email. [655143] [19-1513] [Jon Baughman] [Entered: 12/09/2019 05:04 PM] (7)
Dec 4, 2019 39 REPLY of Appellant Pfizer, Inc. to response [35]. Service: 12/04/2019 by email. [654035] [19-1513] [Catalin Zonte] [Entered: 12/04/2019 02:50 PM] (8)
Dec 3, 2019 38 FILED from Appellant Pfizer, Inc. Title: Appellant's Reply in Support of its Motion to Supplement. Service: 12/03/2019 by email. [653712] [19-1513] --[Edited 12/05/2019 by CAB to revise docket text and add party filer. Document was incorrectly filed as a brief.] This document has been corrected. See Doc. No. [39] [John Scheibeler] [Entered: 12/03/2019 03:25 PM] (11)
Dec 2, 2019 37 FILED from Appellee Chugai Pharmaceutical Co. Ltd. and Appellant Pfizer, Inc. Title: APPENDIX. Service: 12/02/2019 by email. This document has been corrected. See Doc No.[50] [653306] [19-1513]--[Edited 02/03/2020 by JAL to amend docket text] [John Scheibeler] [Entered: 12/02/2019 04:28 PM] (948)
Dec 2, 2019 36 Entry of appearance for Melissa N. Patterson as principal counsel for United States. Service: 12/02/2019 by email. [653167] [19-1513] [Melissa Patterson] [Entered: 12/02/2019 01:32 PM] (1)
Nov 27, 2019 34 MOTION of United States to stay appeal, to extend the time to 01/02/2020 to file Response/Reply [Consent: partial consent]. Service: 11/27/2019 by email. [652775] [19-1513] [Melissa Patterson] [Entered: 11/27/2019 11:40 AM] (8)
Nov 27, 2019 35 RESPONSE of Appellee Chugai Pharmaceutical Co. Ltd. to the motion leave to file supplemental brief [30] filed by Appellant Pfizer, Inc.. Service: 11/27/2019 by email. [653009] [19-1513] [Jon Baughman] [Entered: 11/27/2019 06:00 PM] (7)
Nov 26, 2019 33 RESPONSE of Appellee Chugai Pharmaceutical Co. Ltd. to the motion leave to file supplemental appendix [29] filed by Appellant Pfizer, Inc.. Service: 11/26/2019 by email. [652652] [19-1513] [Jon Baughman] [Entered: 11/26/2019 06:03 PM] (16)
Nov 22, 2019 32 ORDER certifying notice of Pfizer’s constitutional challenge to the Attorney General. The United States’ request to intervene and any response by the United States and Chugai to the motion [30] is due no later than ten days from the date of filing of this order. Any reply in support of the motion is due no later than five days thereafter. Service as of this date by the Clerk of Court. [651769] [NL] [Entered: 11/22/2019 02:43 PM] (2)
Nov 21, 2019 30 MOTION of Pfizer, Inc. for leave to file a supplemental brief [Consent: opposed]. Service: 11/21/2019 by email. [651501] [19-1513]--[Edited 11/22/2019 by MJL to add party filer] [John Scheibeler] [Entered: 11/21/2019 06:26 PM] (17)
Nov 21, 2019 31 FILED from Appellant Pfizer, Inc.. Title: REPLY BRIEF. Service: 11/21/2019 by email. [651502] [19-1513] This document is non-compliant. See Doc No.[47] [John Scheibeler] [Entered: 11/21/2019 06:29 PM] (33)
Nov 21, 2019 29 MOTION of Appellant Pfizer, Inc. leave to file a supplemental appendix [Consent: opposed]. Service: 11/21/2019 by email. [651498] [19-1513] [John Scheibeler] [Entered: 11/21/2019 06:23 PM] (50)
Nov 12, 2019 28 **TEXT ONLY** ORDER granting motion to extend time to file brief [27] filed by Appellant Pfizer, Inc. The reply brief is due 11/21/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [648480] [JAL] [Entered: 11/12/2019 09:19 AM] (0)
Nov 7, 2019 27 MOTION of Appellant Pfizer, Inc. to extend the time to 11/21/2019 to file the Reply Brief. [Consent: unopposed]. Service: 11/07/2019 by email. [647960] [19-1513] [John Scheibeler] [Entered: 11/07/2019 09:23 PM] (8)
Oct 24, 2019 26 MODIFIED ENTRY: RESPONSE BRIEF FILED for Appellee Chugai Pharmaceutical Co. Ltd. Number of Pages: 67. Service: 10/24/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [644401] --[Edited 11/12/2019 by JAL - Compliance review complete] [Jon Baughman] [Entered: 10/24/2019 11:42 AM] (80)
Jul 16, 2019 25 ORDER granting motion to extend time to file Appellee's response brief [24] filed by Appellee Chugai Pharmaceutical Co. Ltd. No further extensions should be anticipated. Brief is due 10/24/2019. Service as of this date by the Clerk of Court. [621344] [TAM] [Entered: 07/16/2019 01:25 PM] (2)
Jul 10, 2019 24 MOTION of Appellee Chugai Pharmaceutical Co. Ltd. to extend the time to 10/24/2019 to file the Responsive Red Brief. [Consent: unopposed]. Service: 07/10/2019 by email. [620154] [19-1513] [Jon Baughman] [Entered: 07/10/2019 04:45 PM] (9)
Jul 2, 2019 23 MODIFIED ENTRY: OPENING BRIEF FILED for Appellant Pfizer, Inc. Number of Pages: 62. Service: 07/02/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [618618] --[Edited 07/17/2019 by TAM - compliance review complete] [John Scheibeler] [Entered: 07/02/2019 02:35 PM] (165)
Jun 3, 2019 22 **TEXT ONLY** ORDER granting motion to withdraw attorney Stephen Maniscalco as counsel [21] filed by Appellee Chugai Pharmaceutical Co. Ltd. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [611062] [TAM] [Entered: 06/03/2019 03:31 PM] (0)
May 31, 2019 21 MOTION of Appellee Chugai Pharmaceutical Co. Ltd. to withdraw counsel Stephen A. Maniscalco [Consent: unopposed]. Service: 05/31/2019 by email. [610712] [19-1513] [Jon Baughman] [Entered: 05/31/2019 12:15 PM] (5)
May 6, 2019 20 **TEXT ONLY** ORDER granting motion to extend time to file Appellant's opening brief [19] filed by Appellant Pfizer, Inc. Brief is due 07/02/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [605029] [TAM] [Entered: 05/06/2019 08:35 AM] (0)
May 3, 2019 19 MOTION of Appellant Pfizer, Inc. to extend the time to 07/02/2019 to file the Appellant Pfizer Inc.'s Opening Brief. [Consent: unopposed]. Service: 05/03/2019 by email. [604997] [19-1513] [John Scheibeler] [Entered: 05/03/2019 05:32 PM] (8)
Apr 25, 2019 18 Entry of appearance for Nicole Lieberman as of counsel for Appellant Pfizer, Inc.. Service: 04/25/2019 by email. [602863] [19-1513] [Nicole Lieberman] [Entered: 04/25/2019 10:54 AM] (2)
Mar 19, 2019 17 Certified list from the United States Patent and Trademark Office. Service: 03/19/2019 by email. Appellant/Petitioner's brief is due 05/20/2019. [595288] [19-1513, 19-1514] [SJ] [Entered: 03/25/2019 03:26 PM] (84)
Feb 22, 2019 16 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:attorney entry of appearance Docket No. [14], ERROR: The contact information included on the entry of appearance for Catalin Sebastian Zonte does not match the information in the attorney's user account. CORRECTION: Pursuant to FCR 47.3(c)(1), please update as needed to ensure the contact information on the entry of appearance and in the user account matches. [587873] [TAM] [Entered: 02/22/2019 09:34 AM] (0)
Feb 21, 2019 15 Entry of appearance for Elizabeth Chang as of counsel for Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587806] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:25 PM] (2)
Feb 21, 2019 14 Entry of appearance for C. Sebastian Zonte as of counsel for Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587805] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:24 PM] (2)
Feb 21, 2019 13 Entry of appearance for Daniel Ledesma as of counsel for Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587804] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:22 PM] (2)
Feb 21, 2019 12 Entry of appearance for Dimitrios Drivas as of counsel for Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587803] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:20 PM] (2)
Feb 21, 2019 11 Entry of appearance for John Scheibeler as principal counsel for Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587802] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:19 PM] (2)
Feb 21, 2019 10 Certificate of Interest for the Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587801] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:18 PM] (3)
Feb 21, 2019 9 Docketing Statement for the Appellant Pfizer, Inc.. Service: 02/21/2019 by email. [587799] [19-1513] [John Scheibeler] [Entered: 02/21/2019 07:16 PM] (4)
Feb 21, 2019 8 Docketing Statement for the Appellee Chugai Pharmaceutical Co. Ltd.. Service: 02/21/2019 by email. [587633] [19-1513] [Jon Baughman] [Entered: 02/21/2019 11:36 AM] (4)
Feb 21, 2019 7 Certificate of Interest for the Appellee Chugai Pharmaceutical Co. Ltd.. Service: 02/21/2019 by email. [587632] [19-1513] [Jon Baughman] [Entered: 02/21/2019 11:34 AM] (3)
Feb 21, 2019 6 Entry of appearance for Stephen A. Maniscalco as of counsel for Appellee Chugai Pharmaceutical Co. Ltd.. Service: 02/21/2019 by email. [587631] [19-1513] [Jon Baughman] [Entered: 02/21/2019 11:31 AM] (2)
Feb 21, 2019 5 Entry of appearance for Megan F. Raymond as of counsel for Appellee Chugai Pharmaceutical Co. Ltd.. Service: 02/21/2019 by email. [587629] [19-1513] [Jon Baughman] [Entered: 02/21/2019 11:29 AM] (2)
Feb 21, 2019 4 Entry of appearance for J. Steven Baughman as principal counsel for Appellee Chugai Pharmaceutical Co. Ltd.. Service: 02/21/2019 by email. [587626] [19-1513] [Jon Baughman] [Entered: 02/21/2019 11:26 AM] (2)
Feb 12, 2019 3 Note to file: The following cases are associated: 19-1513 (Lead) with 19-1514 (Member Case). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [585259] [19-1513, 19-1514] [TAM] [Entered: 02/12/2019 02:01 PM] (0)
Feb 12, 2019 2 ORDER consolidating appeals (19-1513 with 19-1514). Service as of this date by the Clerk of Court. [585258] [19-1513, 19-1514] [TAM] [Entered: 02/12/2019 01:57 PM] (2)
Feb 7, 2019 1 Appeal docketed. Received: 01/30/2019. [583941] Entry of Appearance due 02/21/2019. Certificate of Interest is due on 02/21/2019. Docketing Statement due 02/21/2019. Certified List due on 03/19/2019. [TAM] [Entered: 02/07/2019 08:39 AM] (42)
Menu